Our findings are consistent with a study reported on human bladder cancer cells, where treatment with varying concentrations of NaHS (exogenous H2S donor) led to a significant increase in the expression levels of MMP-2 and MMP-9, along with enhanced invasion capacity [23]. The gene discussed is MMP9; the disease is urinary bladder cancer.